Dycine Pharma
INNOVATION UPDATES MEDIA & EVENTS

Product Innovations

Stay informed about our latest breakthroughs, industry updates and strategic insights from Dycine's experts.

01
Moving into first-in-human trials

VenoShield

Clinical trial plan (CT04) published. Phase I safety studies in healthy volunteers in preparation, followed by Phase II in snakebite patients in high-burden geography.

TimingPhase I ~Q2 2026, Phase II ~Q3 2026
Know More
02
Therapeutic area: Neurological • Schedule H prescription medicine.

Epogres Syrup

FormSuspension ScheduleFSSAI
Know More
03
Diagnostic · Point-of-care

Snake Venom Detection Kit

A 20-minute ELISA diagnostic that identifies venomous & non-venomous bites accurate, timely treatment in remote settings.

Read time20 minutes SpeciesVenomous & Non-venomous UsePOC · field-deployable
Know More
Innovation Updates Media & Events